Urokinase Versus Primary Video-Assisted Thorascopic Surgery for Empyema

This study has been completed.

Sponsored by:	Institute of Child Health
Information provided by:	Institute of Child Health
ClinicalTrials.gov Identifier:	NCT00144950

Purpose

This study will compare VATS versus chest drain insertion and urokinase in the treatment of childhood empema by a randomised prospective study.

Condition	Intervention	Phase
Empyema	Drug: insertion of a chest drain with urokinase instillation Procedure: primary video-assisted thorascopic surgery	Phase I

Drug Information available for: Urokinase

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment

Further study details as provided by Institute of Child Health:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00144950

Locations

United Kingdom
Great Ormond Street Hospital
London, United Kingdom

Sponsors and Collaborators

Institute of Child Health

Investigators

Principal Investigator:

Adam Jaffe, Dr

Great Ormond Street Hospital

More Information

Publications indexed to this study:

Study ID Numbers:	02AR04
Study First Received:	September 2, 2005
Last Updated:	September 2, 2005
ClinicalTrials.gov Identifier:	NCT00144950
Health Authority:	United Kingdom: Research Ethics Committee

Study placed in the following topic categories:

Suppuration
Empyema
Inflammation

Additional relevant MeSH terms:

Pathologic Processes
Infection

ClinicalTrials.gov processed this record on January 16, 2009